Tamiflu®/ Relenza® and Glucose-6-Phosphate Dehydrogenase

Afssaps

Description

Drugs
29/07/2009

Sujets

• DRUGS

Informations

• Publié par: ansm-drugs
• Publié le: 29 juillet 2009
• Nombre de lectures: 253
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, pas de modification
• Langue: English

Extrait

Tamiflu®/ Relenza®
and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency

Oseltamivir

(literature and pharmacovigilance)

Special recommendations for the attention of healthcare professionals

This medicine may be taken.

Instructions for the attention of patients with G6PD deficiency

This medicine may be taken.

Additional information

To date, no haemolytic risk has been identified in subjects with G6PD deficiency for oseltamivir.


Proprietary medicinal products

•TAMIFLU® ,•Lm/IgMmA2T1 UrLeFdwop for oral IFLU®®el paus,gc 75m54
sus e
• TAMpIFnLsUio®30, mgpsca ee luulT MA•capsmg, n

Zanamivir

(literature and pharmacovigilance)

Special recommendations for the attention of healthcare professionals

This medicine may be taken.

Instructions for the attention of patients with G6PD deficiency

This medicine may be taken.

Additional information

To date, no haemolytic risk has been identified in subjects with G6PD deficiency for zanamivir.

Proprietary medicinal products

•RELENZA® in single dose container5mg per dose, powder for inhalation

Afssaps, 07/29/2009